Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-27 | New | $3,978,664 | $3,978,664 | Other | 06b | SEC link |
| 2025-05-20 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2025-03-21 | New | $3,376,350 | $3,376,350 | Other | 06b | SEC link |
| 2025-01-17 | New | $2,404,259 | $2,404,259 | Other | 06b | SEC link |
| 2020-01-17 | New | $455,000 | $455,000 | Equity Only | 06b | SEC link |
| 2019-10-30 | Amended | $7,842,500 | $4,031,000 | Equity Only | 06b | SEC link |
| 2018-10-30 | Amended | $3,811,500 | $940,000 | Equity Only | 06b | SEC link |
| 2018-05-31 | Amended | $2,871,500 | $790,000 | Equity Only | 06b | SEC link |
| 2018-04-03 | New | $2,081,500 | $2,081,500 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Paul Baehr | Director |
| Robert J. De Luccia | Director, Executive |
| Jack H. Dean | Director |
| Robert J. Deluccia | Director, Executive |
| James Donohue | Director |
| Michael Duffy | Director |
| Thomas Harrison | Director |
| Katie Jadhon | Director |
| Anthony Jadhon | Director |
| David P. Luci | Director, Executive |
| Mark Rathjen | Director |
| Carl Sailer | Director |
| Joseph Scodari | Director |
| Robert G. Shawah | Executive |
| John Terrana | Director |